BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 11345288)

  • 21. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM; Mucha SM; Detineo M; Naclerio RM
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis.
    Bronsky EA; Aaronson DW; Berkowitz RB; Chervinsky P; Graft D; Kaiser HB; Moss B; Nathan RA; Pearlman DS; Ratner PH; Adelglass JM; Southern DL; van Bavel J; Hampel F; Stricker WE; Fourré JA; Cuss FM; Nolop KB
    Ann Allergy Asthma Immunol; 1997 Jul; 79(1):51-6. PubMed ID: 9236500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness and tolerability of the glucocorticoid mometasone furoate given as nasal spray in seasonal allergic rhinitis].
    Magyar P; Herjavecz I; Hirschberg A; Kraszkó P; Mohácsi E; Nékám K; Fónay K; Berta G; Györi Z; Márk Z
    Orv Hetil; 2000 Jun; 141(25):1407-11. PubMed ID: 10934885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the allergic reaction in seasonal rhinitis: acoustic rhinometry is a sensitive and objective method.
    Nielsen LP; Bjerke T; Christensen MB; Pedersen B; Rasmussen TR; Dahl R
    Clin Exp Allergy; 1996 Nov; 26(11):1268-75. PubMed ID: 8955576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
    Wang JH; Devalia JL; Rusznak C; Bagnall A; Sapsford RJ; Davies RJ
    Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitis.
    Milanese M; Ricca V; Canonica GW; Ciprandi G
    Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):7-10. PubMed ID: 15745370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily versus self-adjusted dosing of topical mometasone furoate nasal spray in patients with allergic rhinitis: randomised, controlled trial.
    Khan MA; Abou-Halawa AS; Al-Robaee AA; Alzolibani AA; Al-Shobaili HA
    J Laryngol Otol; 2010 Apr; 124(4):397-401. PubMed ID: 19930776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity.
    Ciprandi G; Buscaglia S; Catrullo A; Pesce G; Fiorino N; Montagna P; Bagnasco M; Canonica GW
    Clin Exp Allergy; 1997 Feb; 27(2):182-91. PubMed ID: 9061218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep.
    Meltzer EO; Munafo DA; Chung W; Gopalan G; Varghese ST
    Ann Allergy Asthma Immunol; 2010 Jul; 105(1):65-74. PubMed ID: 20642206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation.
    Baroody FM; Rouadi P; Driscoll PV; Bochner BS; Naclerio RM
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):899-906. PubMed ID: 9517609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions.
    Ciprandi G; Cosentino C; Milanese M; Tosca MA
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):434-8. PubMed ID: 12722967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis.
    Minshall E; Ghaffar O; Cameron L; O'Brien F; Quinn H; Rowe-Jones J; Davies RJ; Prior A; Lund VJ; Mackay IS; Nolop K; Lutsky B; Durham SR; Hamid Q
    Otolaryngol Head Neck Surg; 1998 May; 118(5):648-54. PubMed ID: 9591864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective study on fluticasone propionate aqueous nasal spray efficacy in patients with allergic rhinitis: evaluation of clinical and laboratory parameters.
    Ventura MT; Piccinni T; Matino MG; Giuliano G; Di Corato R; Di Napoli P; Tursi A
    Allergy; 2001 Jan; 56(1):29-34. PubMed ID: 11167349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray.
    Meltzer EO; Jalowayski AA; Orgel HA; Harris AG
    J Allergy Clin Immunol; 1998 Jul; 102(1):39-49. PubMed ID: 9679846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis.
    Anolik R; Nathan RA; Schenkel E; Danzig MR; Gates D; Varghese S
    Int Arch Allergy Immunol; 2008; 147(4):323-30. PubMed ID: 18622139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.